Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Clinical trial NCT01953328 · COMPLETED

Trial details

NCT number: NCT01953328
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events

Start date: 2013-10-01
Primary completion: 2014-06-01
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.